Stay updated on Dapagliflozin at Discharge Reduces Heart Failure Readmission Clinical Trial
Sign up to get notified when there's something new on the Dapagliflozin at Discharge Reduces Heart Failure Readmission Clinical Trial page.

Latest updates to the Dapagliflozin at Discharge Reduces Heart Failure Readmission Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision: v3.4.2 was added and Revision: v3.4.1 was removed in the Study Record History; this routine site-release change does not affect study data or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check20 days agoChange DetectedThe page history now shows Revision: v3.4.1, replacing Revision: v3.4.0. This is a minor metadata update to the page.SummaryDifference0.1%

- Check28 days agoChange DetectedUI updates to the record history page add a glossary toggle, color-coded highlights for additions and deletions, and update the revision label to v3.4.0.SummaryDifference1%

- Check42 days agoChange DetectedThe record history now includes an added Revision: v3.3.4 and the removal of Revision: v3.3.3, a minor update to the history log that does not affect study data or outcomes; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedA new Revision: v3.3.3 entry was added to the record history, while the HHS Vulnerability Disclosure and Revision: v3.3.2 were removed from the footer. These are minor metadata updates to the history page and footer text. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check91 days agoChange DetectedRecord History shows a new revision entry (v3.3.2) added and an older revision (v3.2.0) removed. This is a backend version-tracking update and does not modify study data or visible content.SummaryDifference0.1%

Stay in the know with updates to Dapagliflozin at Discharge Reduces Heart Failure Readmission Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dapagliflozin at Discharge Reduces Heart Failure Readmission Clinical Trial page.